Endocrine Disruptor Service Market Size, Share, Growth, and Industry Analysis, By Type (Endocrine Disruption Screening, Endocrine Disruptor Assessment, & Other Customized Services) By Application (Enterprise & Individual) and Regional Insights and Forecast to 2032

Last Updated: 16 June 2025
SKU ID: 25710532

Trending Insights

Report Icon 1

Global Leaders in Strategy and Innovation Rely on Our Expertise to Seize Growth Opportunities

Report Icon 2

Our Research is the Cornerstone of 1000 Firms to Stay in the Lead

Report Icon 3

1000 Top Companies Partner with Us to Explore Fresh Revenue Channels

ENDOCRINE DISRUPTOR SERVICE MARKET REPORT OVERVIEW

The Endocrine Disruptor Service Market size was valued at approximately USD 4.8 billion in 2023 and is expected to reach USD 8.5 billion by 2032, growing at a compound annual growth rate (CAGR) of about 6.97% from 2024 to 2032.

The endocrine disruptor service market is growing drastically because of the increasing awareness of the impacts of endocrine-disrupting chemicals on health and the environment. Critical services offered in this industry include endocrine disruption screening and risk assessment, among other tailored services to identify and curtail the risks associated with EDCs. It is an area of analytical-technique improvements and development of whole package testing services in conformity with regulatory requirements and increasing consumer demand for access to safer products. 

COVID-19 Impact: Market Growth Accelerated by Pandemic Due to Increased Amount of Emphasis on Health

The global COVID-19 pandemic has been unprecedented and staggering, with the market experiencing higher-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden market growth reflected by the rise in CAGR is attributable to market’s growth and demand returning to pre-pandemic levels.

The COVID-19 pandemic increased health, safety, and environmental matters to a great extent, thus affecting the endocrine disruptor service market. So, with growing awareness related to health risks that EDCs can pose, demand for more efficient screening and testing services grew. This was in terms of industries such as pharmaceuticals, cosmetics, and food manufacturing working to ensure that their products complied with safety standards amid regulatory scrutiny. This thereby put companies offering endocrine disruptor services under higher-than-anticipated demand since businesses had to ensure the safety and compliance of their products.

Additionally, analytical technologies and methods for the detection and assessment of EDCs became more crucial. The pandemic accelerated the activities and investments in research and development of new testing services that would help address the complexities around EDCs. This gave room for elaborate screening exercises that enabled risks to be identified and mitigated. This increase was further sustained by increased cooperation between governments, research institutions, and private companies in the face of public concerns about health, underlining the continuous need for innovation and regulation in the management of endocrine disruptors​.

LATEST TRENDS

Growing Pressure of Regulations and Emphasis on Environmental Safety in Endocrine Disruptor Service Market to Drive Market Growth.

Due to the potential impact of EDCs on human health and ecosystems, there is now increased focus from many governments and international organizations on identification and management. This has tabled ways to strict legislations and testing, thereby increasing the demand for endocrine disruptor analysis services as industries seek to comply with these regulations​. The growing awareness among consumers and industries about the health effects of EDCs impels them to drive the demand for testing and assessment services. This is especially notable in sectors like cosmetics, food and beverages, and agriculture, where the need for EDC-free certifications of products is growing. Companies' raising their spending on research and development to innovate and improve testing technologies further drives market growth.

Endocrine-Disruptor-Service-Market-Share,-By-Application,-2032

ask for customizationRequest a Free sample to learn more about this report

ENDOCRINE DISRUPTOR SERVICE MARKET SEGMENTATION

By Type

Based on type the global market can be categorized into Endocrine Disruption Screening, Endocrine Disruptor Assessment, & Other Customized Services.

  • Endocrine disruption screening: In this testing is carried out, which is the initial testing and screening of chemicals for their potential to interfere with the endocrine system. It shall employ a battery of in vitro and in vivo methods to identify endocrine-disrupting properties. Consequently, it will be very important in early identification and compliance with regulation.
  • Endocrine Disruptor Assessment: Detailed chemical assessment claimed to have some possibility of acting as an endocrine disruptor. It provides a full risk assessment that takes into consideration exposure levels and toxicological data, together with the probable impacts on human health and the environment, for a complete understanding of the risks associated.
  • Other Customized Services: This is a segment offering solutions to the specified industrial needs by providing custom testing protocols, consultancy in regulations, and reviews in product safety. These services aim at helping enterprises to navigate through complex regulatory landscapes that let them be easy and safe to both customers and the environment. ​

By Application

Based on application the global market can be categorized into Enterprise & Individual.

  • Enterprise: This involves businesses and industries that require endocrine disruptor services to ascertain that their products are in line with regulations and are safe. Firms involved in the pharmaceutical and cosmetic industries, as well as agricultural and food product manufacturing, utilize such services to have their products checked and certified against EDCs both for consumer health and environmental impact​.
  • Individual: The individual consumer is ever more conscious of the possible health risks coming from EDCs. Such services are, therefore, oriented towards education in regard to EDCs and provide individual assessments or recommendations to reduce one's exposure to harmful chemicals in everyday products.

DRIVING FACTORS

Increasing Regulatory Pressure to Boost the Market

The increasing regulatory pressure is one of the major driving factors that boost the endocrine disruptor service market. Several governments and international organizations, like the European Union and the U.S. Environmental Protection Agency, are taking leading initiatives to enforce strict regulations on the usage and monitoring of EDCs due to their potential harmful effects on health and the environment ​. This regulatory environment compels industries to maintain safety standards through rigorous testing and assessment of products. Consequently, growing demand for endocrine disruptor services is created to enable these regulatory requirements, which drives market growth​.

Consumer awareness about the potential health risk from EDCs to Expand the Market

The consumer is becoming slowly aware of EDC-associated health risks, hence expanding the market scope of endocrine disruptor services. An increasing number of manufacturers is assuring that there are safer, less toxic options in store for consumers due to this growing awareness.

RESTRAINING FACTORS

High Cost of Testing and Analysis to Potentially Impede Market Growth

This forms a major restraining force that hinders the Endocrine Disruptor Service market growth. The high costs associated with testing and analysis. Advanced technologies and methodologies to conduct comprehensive endocrine disruption screening and assessment are expensive. Small- and medium-sized enterprises will find it hard to afford such services, while failure to afford some of these techniques could easily shut out the option of compliance with the regulatory requirements or servicing the consumer demand for safety ​. The cost barrier may impede market growth, especially in places where the regulatory framework is yet to take off the ground and people are tightfisted.

ENDOCRINE DISRUPTOR SERVICE MARKET REGIONAL INSIGHTS

North America Region is dominating the endocrine disruptor service market due to the massive contribution share of this region.

The market is primarily segregated into Europe, Latin America, Asia Pacific, North America, and Middle East & Africa.

North America dominates in the endocrine disruptor service market share. This is attributed to the massive contribution share of this region, which results from various factors such as the presence of well-established pharmaceutical and biotechnology industries, rising government initiatives for environmental protection, and increased awareness about the impact of endocrine disruptors on health. Dominance over the North American regional market is expected, especially due to the United States, driven by advanced research and development capabilities and a stringent regulatory framework in terms of chemical safety and environmental protection​.

This market is further supported by the presence of several major key players and research institutions focused on endocrine disruptor testing and assessment based in North America. Key companies develop innovative solutions and services to meet the growing demand for effective testing methods in the region. Continuous commitment of this region towards addressing public health concerns pertaining to endocrine disruptors continues to fuel growth and maintain its leading position in the global market​.

KEY INDUSTRY PLAYERS

Key Industry Players Shaping the Market through Innovation and Market Expansion

The main market participants of the endocrine disruptor service market hold a very strong dominance in the market through constant innovation and process development in the market; for example, Eurofins Scientific, Charles River Laboratories, and Intertek are the major companies providing a wide range of services in testing and evaluation for EDCs. It will be expanded to fulfill the customers' demands and the burgeoning demands of products that are safe and compliant through advanced technologies and methodologies in exact and efficient solutions. They invest in research and development to improve the quality of their service provision and strive to stay ahead.

Some of the other market performing factors that are utilized by the major players include strategic partnerships, acquisitions, and venturing into new geographical markets, especially in emerging markets. For instance, Eurofins Scientific has stepped up to create bases in various markets through the acquisition of regional laboratories and facilities that help it to offer local services and meet the regional regulatory requirements, thus improving its bottom line. These strategies provide the companies the ability to reach a larger number of clients, meet the increased demand for EDC testing, and comply with the diverse regulatory standards. They are proactive measures that enhance their market positions, driving overall market growth.

List of Top Endocrine Disruptor Service Companies

  • Eurofins Scientific (Luxembourg)
  • Charles River Laboratories (USA)
  • Creative Proteomics (USA)
  • LAUS Corp.(Germany)
  • Malvern Panalytical (UK)
  • Creative Bioarray (USA)
  • ZeClinics (Spain)
  • Xenometrix (Switzerland)
  • ToxStrategies (USA)
  • Smithers (USA)
  • Intertek (UK)
  • Fera Science (UK)
  • PerkinElmer (USA)
  • Compliance Services International (USA)
  • Stellixir Biotech (India)

INDUSTRIAL DEVELOPMENT

June 2024: One of the major events in the endocrine disruptor service market was the expansion by Eurofins Scientific, who has been at the forefront globally in regard to testing and laboratory services. The company further strengthened its portfolio in endocrine disruptors screening services through the introduction of state-of-the-art in vitro testing methods. These would allow for the most precise and comprehensive detection of endocrine disruptors in consumer goods and environmental samples. The expansion will be necessary due to the increasing demand from industries for dependable testing services to ascertain the safety and global standard conformance of various products, coupled with intensified regulatory scrutiny.

REPORT COVERAGE

The study encompasses a comprehensive SWOT analysis and provides insights into future developments within the market. It examines various factors that contribute to the growth of the market, exploring a wide range of market categories and potential applications that may impact its trajectory in the coming years. The analysis takes into account both current trends and historical turning points, providing a holistic understanding of the market's components and identifying potential areas for growth.

The research report delves into market segmentation, utilizing both qualitative and quantitative research methods to provide a thorough analysis. It also evaluates the impact of financial and strategic perspectives on the market. Furthermore, the report presents national and regional assessments, considering the dominant forces of supply and demand that influence market growth. The competitive landscape is meticulously detailed, including market shares of significant competitors. The report incorporates novel research methodologies and player strategies tailored for the anticipated timeframe. Overall, it offers valuable and comprehensive insights into the market dynamics in a formal and easily understandable manner.

Endocrine Disruptor Service Market Report Scope & Segmentation

Attributes Details

Market Size Value In

US$ 4.8 Billion in 2023

Market Size Value By

US$ 8.5 Billion by 2032

Growth Rate

CAGR of 6.97% from 2024to2032

Forecast Period

2024-2032

Base Year

2024

Historical Data Available

Yes

Regional Scope

Global

Segments Covered

By Type

  • Endocrine Disruption Screening
  • Endocrine Disruptor Assessment
  • Other Customized Services

By Application

  • Enterprise
  • Individual

FAQs